{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:24:16Z","timestamp":1782257056416,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10689-020-00219-9","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T02:02:48Z","timestamp":1609725768000},"page":"241-251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hereditary medullary thyroid carcinoma syndromes: experience from western India"],"prefix":"10.1007","volume":"20","author":[{"given":"Chakra","family":"Diwaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya","family":"Sarathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeet Kumar","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravikumar","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuja","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand Ebin","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagan","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virendra","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Lila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalini","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6902-4639","authenticated-orcid":false,"given":"Tushar","family":"Bandgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"219_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ecl.2018.11.006","volume":"48","author":"D Viola","year":"2019","unstructured":"Viola D, Elisei R (2019) Management of medullary thyroid cancer. Endocrinol Metab Clin North Am 48:285\u2013301. https:\/\/doi.org\/10.1016\/j.ecl.2018.11.006","journal-title":"Endocrinol Metab Clin North Am"},{"key":"219_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1530\/EJE-14-0817","volume":"172","author":"H-L Sarika","year":"2015","unstructured":"Sarika H-L, Papathoma A, Garofalaki M et al (2015) Genetic screening of patients with medullary thyroid cancer in a referral center in greece during the past two decades. Eur J Endocrinol 172:501\u2013509. https:\/\/doi.org\/10.1530\/EJE-14-0817","journal-title":"Eur J Endocrinol"},{"key":"219_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1530\/EJE-10-0333","volume":"163","author":"C Romei","year":"2010","unstructured":"Romei C, Mariotti S, Fugazzola L et al (2010) Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. Eur J Endocrinol 163:301\u2013308. https:\/\/doi.org\/10.1530\/EJE-10-0333","journal-title":"Eur J Endocrinol"},{"key":"219_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.14310\/horm.2002.1218","volume":"8","author":"F Raue","year":"2009","unstructured":"Raue F, Frank-Raue K (2009) Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management. Horm Athens Greece 8:23\u201328. https:\/\/doi.org\/10.14310\/horm.2002.1218","journal-title":"Horm Athens Greece"},{"key":"219_CR5","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1210\/js.2018-00178","volume":"2","author":"F Raue","year":"2018","unstructured":"Raue F, Frank-Raue K (2018) Update on multiple endocrine neoplasia type 2: focus on medullary thyroid carcinoma. J Endocr Soc 2:933\u2013943. https:\/\/doi.org\/10.1210\/js.2018-00178","journal-title":"J Endocr Soc"},{"key":"219_CR6","doi-asserted-by":"publisher","first-page":"T29","DOI":"10.1530\/ERC-17-0209","volume":"25","author":"F Castinetti","year":"2018","unstructured":"Castinetti F, Moley J, Mulligan L, Waguespack SG (2018) A comprehensive review on MEN2B. Endocr Relat Cancer 25:T29\u2013T39. https:\/\/doi.org\/10.1530\/ERC-17-0209","journal-title":"Endocr Relat Cancer"},{"key":"219_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells","year":"2015","unstructured":"Wells SA, Asa SL, Dralle H et al (2015) Revised american thyroid association guidelines for the management of medullary thyroid carcinoma. Thyroid Off J Am Thyroid Assoc 25:567\u2013610. https:\/\/doi.org\/10.1089\/thy.2014.0335","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"219_CR8","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/humu.23430","volume":"39","author":"A Machens","year":"2018","unstructured":"Machens A, Lorenz K, Weber F, Dralle H (2018) Genotype-specific progression of hereditary medullary thyroid cancer. Hum Mutat 39:860\u2013869. https:\/\/doi.org\/10.1002\/humu.23430","journal-title":"Hum Mutat"},{"key":"219_CR9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10689-010-9320-2","volume":"9","author":"F Raue","year":"2010","unstructured":"Raue F, Frank-Raue K (2010) Update multiple endocrine neoplasia type 2. Fam Cancer 9:449\u2013457. https:\/\/doi.org\/10.1007\/s10689-010-9320-2","journal-title":"Fam Cancer"},{"key":"219_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1530\/EJE-12-1106","volume":"168","author":"T Imai","year":"2013","unstructured":"Imai T, Uchino S, Okamoto T et al (2013) High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients. Eur J Endocrinol 168:683\u2013687. https:\/\/doi.org\/10.1530\/EJE-12-1106","journal-title":"Eur J Endocrinol"},{"key":"219_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S2213-8587(18)30336-X","volume":"7","author":"F Castinetti","year":"2019","unstructured":"Castinetti F, Waguespack SG, Machens A et al (2019) Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study. Lancet Diabetes Endocrinol 7:213\u2013220. https:\/\/doi.org\/10.1016\/S2213-8587(18)30336-X","journal-title":"Lancet Diabetes Endocrinol"},{"key":"219_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10689-016-9892-6","volume":"15","author":"JO Scapineli","year":"2016","unstructured":"Scapineli JO, Ceolin L, Pu\u00f1ales MK et al (2016) MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics. Fam Cancer 15:625\u2013633. https:\/\/doi.org\/10.1007\/s10689-016-9892-6","journal-title":"Fam Cancer"},{"key":"219_CR13","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1089\/thy.2005.15.618","volume":"15","author":"SL-S Barbosa","year":"2005","unstructured":"Barbosa SL-S, Rodien P, Leboulleux S et al (2005) Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature. Thyroid Off J Am Thyroid Assoc 15:618\u2013623. https:\/\/doi.org\/10.1089\/thy.2005.15.618","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"219_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s12038-011-9095-0","volume":"36","author":"BP Sharma","year":"2011","unstructured":"Sharma BP, Saranath D (2011) RET gene mutations and polymorphisms in medullary thyroid carcinomas in Indian patients. J Biosci 36:603\u2013611. https:\/\/doi.org\/10.1007\/s12038-011-9095-0","journal-title":"J Biosci"},{"key":"219_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1445-2197.2006.03992.x","volume":"77","author":"P Finny","year":"2007","unstructured":"Finny P, Jacob JJ, Thomas N et al (2007) Medullary thyroid carcinoma: a 20-year experience from a centre in South India. ANZ J Surg 77:130\u2013134. https:\/\/doi.org\/10.1111\/j.1445-2197.2006.03992.x","journal-title":"ANZ J Surg"},{"key":"219_CR16","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s12070-018-1492-3","volume":"70","author":"J Bakshi","year":"2018","unstructured":"Bakshi J, Patro SK, Kaur N et al (2018) Understanding malignancies of the thyroid gland: institutional experience. Indian J Otolaryngol Head Neck Surg 70:482\u2013489. https:\/\/doi.org\/10.1007\/s12070-018-1492-3","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"219_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s13193-017-0718-2","volume":"9","author":"AJ Cherian","year":"2018","unstructured":"Cherian AJ, Ramakant P, Pai R et al (2018) Outcome of treatment for medullary thyroid carcinoma-a single centre experience. Indian J Surg Oncol 9:52\u201358. https:\/\/doi.org\/10.1007\/s13193-017-0718-2","journal-title":"Indian J Surg Oncol"},{"key":"219_CR18","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00268-011-1086-7","volume":"35","author":"PK Mehrotra","year":"2011","unstructured":"Mehrotra PK, Mishra A, Mishra SK et al (2011) Medullary thyroid cancer: clinico-pathological profile and outcome in a tertiary care center in north India. World J Surg 35:1273\u20131280. https:\/\/doi.org\/10.1007\/s00268-011-1086-7","journal-title":"World J Surg"},{"key":"219_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4103\/0973-1482.180611","volume":"14","author":"AA Shah","year":"2018","unstructured":"Shah AA, Jain PP, Dubey AS et al (2018) A study of clinicopathological characteristics of thyroid carcinoma at a tertiary care center. J Cancer Res Ther 14:357\u2013360. https:\/\/doi.org\/10.4103\/0973-1482.180611","journal-title":"J Cancer Res Ther"},{"key":"219_CR20","doi-asserted-by":"publisher","first-page":"516","DOI":"10.4103\/2230-8210.137508","volume":"18","author":"DM Mahesh","year":"2014","unstructured":"Mahesh DM, Nehru AG, Seshadri MS et al (2014) RET mutations in a large indian family with medullary thyroid carcinoma. Indian J Endocrinol Metab 18:516\u2013520. https:\/\/doi.org\/10.4103\/2230-8210.137508","journal-title":"Indian J Endocrinol Metab"},{"key":"219_CR21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1365-2265.2011.04069.x","volume":"75","author":"R Pai","year":"2011","unstructured":"Pai R, Nehru GA, Samuel P et al (2011) Mutational analysis of RET proto-oncogene among patients with medullary thyroid carcinoma and \u201cat risk\u201d carriers from India. Clin Endocrinol (Oxf) 75:571\u2013572. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04069.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"219_CR22","doi-asserted-by":"publisher","first-page":"X3","DOI":"10.1530\/EJE-16-0126e","volume":"175","author":"R Pandit","year":"2016","unstructured":"Pandit R, Khadilkar K, Sarathi V et al (2016) Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma. Eur J Endocrinol 175:X3. https:\/\/doi.org\/10.1530\/EJE-16-0126e","journal-title":"Eur J Endocrinol"},{"key":"219_CR23","doi-asserted-by":"publisher","first-page":"759","DOI":"10.4158\/EP11058.OR","volume":"17","author":"V Sarathi","year":"2011","unstructured":"Sarathi V, Pandit R, Jagtap V et al (2011) Performance of plasma fractionated free metanephrines by enzyme immunoassay in the diagnosis of pheochromocytoma and paraganglioma. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 17:759\u2013765. https:\/\/doi.org\/10.4158\/EP11058.OR","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"219_CR24","doi-asserted-by":"publisher","first-page":"694","DOI":"10.4158\/EP12050.OR","volume":"18","author":"V Sarathi","year":"2012","unstructured":"Sarathi V, Pandit R, Patil VK et al (2012) Performance of plasma fractionated free metanephrines by enzyme immunoassay in the diagnosis of pheochromocytoma and paraganglioma in children. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 18:694\u2013699. https:\/\/doi.org\/10.4158\/EP12050.OR","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"219_CR25","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/cen.13406","volume":"87","author":"M Goroshi","year":"2017","unstructured":"Goroshi M, Lila AR, Jadhav SS et al (2017) Percentage arterial enhancement: an objective index for accurate identification of parathyroid adenoma\/hyperplasia in primary hyperparathyroidism. Clin Endocrinol (Oxf) 87:791\u2013798. https:\/\/doi.org\/10.1111\/cen.13406","journal-title":"Clin Endocrinol (Oxf)"},{"key":"219_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/hed.25463","volume":"41","author":"K Saltiki","year":"2019","unstructured":"Saltiki K, Simeakis G, Anagnostou E et al (2019) Different outcomes in sporadic versus familial medullary thyroid cancer. Head Neck 41:154\u2013161. https:\/\/doi.org\/10.1002\/hed.25463","journal-title":"Head Neck"},{"key":"219_CR27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1089\/thy.2006.0229","volume":"17","author":"S Grozinsky-Glasberg","year":"2007","unstructured":"Grozinsky-Glasberg S, Benbassat CA, Tsvetov G et al (2007) Medullary thyroid cancer: a retrospective analysis of a cohort treated at a single tertiary care center between 1970 and 2005. Thyroid Off J Am Thyroid Assoc 17:549\u2013556. https:\/\/doi.org\/10.1089\/thy.2006.0229","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"219_CR28","doi-asserted-by":"publisher","first-page":"278","DOI":"10.4174\/astr.2016.91.6.278","volume":"91","author":"CR Lee","year":"2016","unstructured":"Lee CR, Lee S, Son H et al (2016) Medullary thyroid carcinoma: a 30-year experience at one institution in Korea. Ann Surg Treat Res 91:278\u2013287. https:\/\/doi.org\/10.4174\/astr.2016.91.6.278","journal-title":"Ann Surg Treat Res"},{"key":"219_CR29","doi-asserted-by":"publisher","unstructured":"Raue F, Frankraue K 2015 Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma. 61\u201390. https:\/\/doi.org\/https:\/\/doi.org\/10.1007\/978-3-319-22542-5","DOI":"10.1007\/978-3-319-22542-5"},{"key":"219_CR30","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.4158\/EP13171.OR","volume":"19","author":"HR Kakade","year":"2013","unstructured":"Kakade HR, Kasaliwal R, Jagtap VS et al (2013) Ectopic ACTH-secreting syndrome: a single-center experience. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 19:1007\u20131014. https:\/\/doi.org\/10.4158\/EP13171.OR","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"219_CR31","doi-asserted-by":"publisher","first-page":"907","DOI":"10.4158\/EP161677.OR","volume":"23","author":"S Sathyakumar","year":"2017","unstructured":"Sathyakumar S, Paul TV, Asha HS et al (2017) Ectopic cushing syndrome: a 10-year experience from a tertiary care center in Southern India. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 23:907\u2013914. https:\/\/doi.org\/10.4158\/EP161677.OR","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"219_CR32","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1365-2265.2006.02659.x","volume":"65","author":"JWB de Groot","year":"2006","unstructured":"de Groot JWB, Plukker JTM, Wolffenbuttel BHR et al (2006) Determinants of life expectancy in medullary thyroid cancer: age does not matter. Clin Endocrinol (Oxf) 65:729\u2013736. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02659.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"219_CR33","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/(sici)1097-0142(20000301)88:5<1139::aid-cncr26>3.0.co;2-z","volume":"88","author":"E Kebebew","year":"2000","unstructured":"Kebebew E, Ituarte PH, Siperstein AE et al (2000) Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88:1139\u20131148. https:\/\/doi.org\/10.1002\/(sici)1097-0142(20000301)88:5%3c1139::aid-cncr26%3e3.0.co;2-z","journal-title":"Cancer"},{"key":"219_CR34","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s004230050143","volume":"383","author":"F Raue","year":"1998","unstructured":"Raue F (1998) German medullary thyroid carcinoma\/multiple endocrine neoplasia registry. German MTC\/MEN study group. Medullary thyroid carcinoma\/multiple endocrine neoplasia type 2. Langenbecks Arch Surg 383:334\u2013336. https:\/\/doi.org\/10.1007\/s004230050143","journal-title":"Langenbecks Arch Surg"},{"key":"219_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ejso.2004.11.002","volume":"31","author":"H Sl","year":"2004","unstructured":"Sl H, K N, C H, (2004) Familial medullary thyroid cancer: clinical aspects and prognosis. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 31:415\u2013419. https:\/\/doi.org\/10.1016\/j.ejso.2004.11.002","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"219_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.surg.2016.04.053","volume":"161","author":"RW Randle","year":"2017","unstructured":"Randle RW, Balentine CJ, Leverson GE et al (2017) Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Surgery 161:137\u2013146. https:\/\/doi.org\/10.1016\/j.surg.2016.04.053","journal-title":"Surgery"},{"key":"219_CR37","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1365-2265.2009.03666.x","volume":"72","author":"JAA Meijer","year":"2010","unstructured":"Meijer JAA, Le Cessie S, Van Den Hout WB et al (2010) Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis. Clin Endocrinol (Oxf) 72:534\u2013542. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03666.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"219_CR38","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1210\/jc.2019-00516","volume":"104","author":"F Raue","year":"2019","unstructured":"Raue F, Bruckner T, Frank-Raue K (2019) Long-term outcomes and aggressiveness of hereditary medullary thyroid carcinoma: 40 years of experience at one center. J Clin Endocrinol Metab 104:4264\u20134272. https:\/\/doi.org\/10.1210\/jc.2019-00516","journal-title":"J Clin Endocrinol Metab"},{"key":"219_CR39","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1089\/thy.2018.0564","volume":"29","author":"JS Mathiesen","year":"2019","unstructured":"Mathiesen JS, Kroustrup JP, Vestergaard P et al (2019) Survival and long-term biochemical cure in medullary thyroid carcinoma in Denmark 1997\u20132014: a nationwide study. Thyroid 29:368\u2013377. https:\/\/doi.org\/10.1089\/thy.2018.0564","journal-title":"Thyroid"},{"key":"219_CR40","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2017-00317","volume":"102","author":"RK Voss","year":"2017","unstructured":"Voss RK, Feng L, Lee JE et al (2017) Medullary thyroid carcinoma in MEN2A: ATA moderate- or high-risk RET mutations do not predict disease aggressiveness. J Clin Endocrinol Metab 102:2807\u20132813. https:\/\/doi.org\/10.1210\/jc.2017-00317","journal-title":"J Clin Endocrinol Metab"},{"key":"219_CR41","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1210\/jc.2009-2368","volume":"95","author":"A Machens","year":"2010","unstructured":"Machens A, Dralle H (2010) Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab 95:2655\u20132663. https:\/\/doi.org\/10.1210\/jc.2009-2368","journal-title":"J Clin Endocrinol Metab"},{"key":"219_CR42","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s00268-015-3255-6","volume":"40","author":"S Rajan","year":"2016","unstructured":"Rajan S, Zaidi G, Agarwal G et al (2016) Genotype-phenotype correlation in indian patients with MEN2-associated pheochromocytoma and comparison of clinico-pathological attributes with apparently sporadic adrenal pheochromocytoma. World J Surg 40:690\u2013696. https:\/\/doi.org\/10.1007\/s00268-015-3255-6","journal-title":"World J Surg"},{"key":"219_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1210\/jc.2018-00705","volume":"104","author":"A Makri","year":"2019","unstructured":"Makri A, Akshintala S, Derse-Anthony C et al (2019) Pheochromocytoma in children and adolescents with multiple endocrine neoplasia type 2B. J Clin Endocrinol Metab 104:7\u201312. https:\/\/doi.org\/10.1210\/jc.2018-00705","journal-title":"J Clin Endocrinol Metab"},{"key":"219_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1210\/jc.2017-01884","volume":"103","author":"F Raue","year":"2018","unstructured":"Raue F, Dralle H, Machens A et al (2018) Long-term survivorship in multiple endocrine neoplasia type 2B diagnosed before and in the new millennium. J Clin Endocrinol Metab 103:235\u2013243. https:\/\/doi.org\/10.1210\/jc.2017-01884","journal-title":"J Clin Endocrinol Metab"},{"key":"219_CR45","doi-asserted-by":"publisher","first-page":"E1813","DOI":"10.1210\/jc.2013-1653","volume":"98","author":"S Thosani","year":"2013","unstructured":"Thosani S, Ayala-Ramirez M, Palmer L et al (2013) The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 98:E1813-1819. https:\/\/doi.org\/10.1210\/jc.2013-1653","journal-title":"J Clin Endocrinol Metab"},{"key":"219_CR46","doi-asserted-by":"publisher","first-page":"E336","DOI":"10.1210\/jc.2012-3192","volume":"98","author":"A Machens","year":"2013","unstructured":"Machens A, Lorenz K, Dralle H (2013) Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening. J Clin Endocrinol Metab 98:E336-345. https:\/\/doi.org\/10.1210\/jc.2012-3192","journal-title":"J Clin Endocrinol Metab"},{"key":"219_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/humu.21385","volume":"32","author":"K Frank-Raue","year":"2011","unstructured":"Frank-Raue K, Rybicki LA, Erlic Z et al (2011) Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. Hum Mutat 32:51\u201358. https:\/\/doi.org\/10.1002\/humu.21385","journal-title":"Hum Mutat"},{"key":"219_CR48","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s12020-020-02232-5","volume":"68","author":"A Machens","year":"2020","unstructured":"Machens A, Elwerr M, Lorenz K et al (2020) 100-Year evolution of precision medicine and surgery for multiple endocrine neoplasia type 2A. Endocrine 68:368\u2013376. https:\/\/doi.org\/10.1007\/s12020-020-02232-5","journal-title":"Endocrine"},{"key":"219_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2019.8898","volume":"2","author":"HPH Neumann","year":"2019","unstructured":"Neumann HPH, Tsoy U, Bancos I et al (2019) Comparison of pheochromocytoma-specific morbidity and mortality among adults with bilateral pheochromocytomas undergoing total adrenalectomy vs cortical-sparing adrenalectomy. JAMA Netw Open 2:1\u201313. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.8898","journal-title":"JAMA Netw Open"},{"key":"219_CR50","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S1470-2045(14)70154-8","volume":"15","author":"F Castinetti","year":"2014","unstructured":"Castinetti F, Qi X-P, Walz MK et al (2014) Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. Lancet Oncol 15:648\u2013655. https:\/\/doi.org\/10.1016\/S1470-2045(14)70154-8","journal-title":"Lancet Oncol"},{"key":"219_CR51","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4103\/0022-3859.65279","volume":"56","author":"RA Gopal","year":"2010","unstructured":"Gopal RA, Acharya SV, Bandgar T et al (2010) Clinical profile of primary hyperparathyroidism from western India: a single center experience. J Postgrad Med 56:79\u201384. https:\/\/doi.org\/10.4103\/0022-3859.65279","journal-title":"J Postgrad Med"},{"key":"219_CR52","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00774-017-0833-8","volume":"36","author":"SK Bhadada","year":"2018","unstructured":"Bhadada SK, Arya AK, Mukhopadhyay S et al (2018) Primary hyperparathyroidism: insights from the Indian PHPT registry. J Bone Miner Metab 36:238\u2013245. https:\/\/doi.org\/10.1007\/s00774-017-0833-8","journal-title":"J Bone Miner Metab"},{"key":"219_CR53","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/SLA.0000000000001464","volume":"262","author":"JF Moley","year":"2015","unstructured":"Moley JF, Skinner M, Gillanders WE et al (2015) Management of the parathyroid glands during preventive thyroidectomy in patients with multiple endocrine neoplasia type 2. Ann Surg 262:641\u2013646. https:\/\/doi.org\/10.1097\/SLA.0000000000001464","journal-title":"Ann Surg"},{"key":"219_CR54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1750-1172-8-50","volume":"8","author":"BA Twigt","year":"2013","unstructured":"Twigt BA, Scholten A, Valk GD et al (2013) Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-up. Orphanet J Rare Dis 8:50. https:\/\/doi.org\/10.1186\/1750-1172-8-50","journal-title":"Orphanet J Rare Dis"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-020-00219-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-020-00219-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-020-00219-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T06:09:43Z","timestamp":1624082983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-020-00219-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["219"],"URL":"https:\/\/doi.org\/10.1007\/s10689-020-00219-9","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"21 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}